Question 1

Does UBS Asset Management Americas own FATE stock?

Accepted Answer

Yes. As of its Q2 2026 13F, UBS Asset Management Americas holds 815 shares of FATE (Fate Therapeutics), worth $2,201.

Question 2

How many shares of FATE does UBS Asset Management Americas own?

Accepted Answer

As of its Q2 2026 13F, UBS Asset Management Americas holds 815 shares of FATE (Fate Therapeutics).

Question 3

What is UBS Asset Management Americas' FATE position worth?

Accepted Answer

As of its Q2 2026 13F, UBS Asset Management Americas' FATE position is worth $2,201.

Question 4

When did UBS Asset Management Americas first buy FATE?

Accepted Answer

UBS Asset Management Americas already held FATE in its Q4 2018 13F, the earliest on record, and has listed it in 24 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Unchanged	815	0.0%	$2,201	0.0%	$2.70	0
2026-Q1	New	815	—	$978	0.0%	$1.20	17
2024-Q4	Exited	0	-100.0%	$0	0.0%	$1.65	0
2024-Q3	Decreased	142,131	-24.6%	$497,459	0.0%	$3.50	0